case 3: managing immune-related adverse effects in tnbc
Published 4 years ago • 12 plays • Length 2:24Download video MP4
Download video MP3
Similar videos
-
5:54
case 3: treatment after progression in triple-negative breast cancer
-
4:40
case 3: the use of combination therapy in triple-negative breast cancer
-
3:37
case 3: pd-l1 testing used in triple-negative breast cancer
-
2:10
testing and targeted therapy in triple negative breast cancer: 2023 west oncology
-
7:42
the complexities of battling triple-negative breast cancer
-
15:44
immunology q3
-
13:38
near complete remission in stage 4 triple negative breast cancer | #integrativeoncology | aohc
-
2:26
case 3: metastatic triple-negative breast cancer
-
5:45
case 3: atezolizumab/nab-paclitaxel for triple negative breast cancer
-
38:56
navigating the management of triple-negative breast cancer: immunotherapy considerations
-
1:34
strategies to improve the response to immunotherapy in tnbc
-
1:00:46
triple negative breast cancer case panel discussion | 2022 best of breast conference
-
8:24
understanding breast cancer
-
2:44
impassion130: addressing immune-related aes in tnbc management
-
1:39:18
expanding the benefits of checkpoint inhibitors and targeted agents in triple-negative breast cancer
-
1:04:28
harnessing the immune system in the treatment of triple-negative breast cancer
-
3:38
nccn animation for patients: overview of triple-negative breast cancer (tnbc)
-
31:24
harnessing the immune system in the treatment of triple-negative breast cancer
-
1:08:58
tnbc current and emerging therapeutic strategies | 2023 best of breast conference
-
8:15
what is triple-negative breast cancer, and how is it treated?
-
1:00
overcoming challenges in treating patients with triple-negative breast cancer
-
36:33
breast cancer case-based panel discussion | 2022 midwest women's cancer conference